Quidel to Hold First Quarter 2013 Financial Results

New Post Public Reply Private Reply Replies (0) Message Board
testuser
Quidel to Hold First Quarter 2013 Financial Results Conference Call on April 23, 2013

SAN DIEGO, CA--(Marketwired - Apr 10, 2013) - Quidel Corporation ( NASDAQ : QDEL ), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic solutions, will release first quarter 2013 financial results after market close on Tuesday, April 23, 2013.

Following the release of results, Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial officer, will host an investment community conference call beginning at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the results and answer questions. During the conference call, the company will also discuss business and financial developments and trends. The company's statements may contain or constitute material information that has not been previously disclosed.

To participate in the live call by telephone from the U.S., dial 866-515-2913 , or from outside the U.S. dial 617-399-5127 , and enter the pass code 64054813.

A live webcast of the call can be accessed at http://www.quidel.com , and the Web site replay will be available for 14 days. The telephone replay will be available for 48 hours beginning at 7:00 p.m. Eastern Time (4:00 p.m. Pacific Time) on April 23 by dialing 888-286-8010 from the U.S., or 617-801-6888 for international callers, and entering pass code 61483202.

About Quidel Corporation

Quidel Corporation serves to enhance the health and well being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system. Marketed under the QuickVue®, D3® Direct Detection and Thyretain® leading brand names, as well as under the new Sofia® and AmpliVue® brands, Quidel's products aid in the detection and diagnosis of many critical diseases and conditions, including, among others, influenza , respiratory syncytial virus , Strep A, herpes, pregnancy, thyroid disease and fecal occult blood . Quidel's research and development engine is also developing a continuum of diagnostic solutions from advanced lateral-flow and direct fluorescent antibody to molecular diagnostic tests to further improve the quality of healthcare in physicians' offices and hospital and reference laboratories. For more information about Quidel's comprehensive product portfolio, visit www.quidel.com and Diagnostic Hybrids at www.dhiusa.com .

Quidel Contact: Quidel Corporation Randy Steward Chief Financial Officer (858) 552-7931 Media and Investors Contact: Quidel Corporation Ruben Argueta (858) 646-8023 Email Contact

Investors-Hangout-Stock-Message-Boards-thumbnail-2015.png

test123 kjk
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MoreBetter's Therapy Co-Investment: A Big Bet on Patient Data

Updated Category News Views 62

Diving Into Uncharted Waters with Bold Moves MoreBetter is stepping right into the murky, unpredictable world of longevity, peptide, and psychedelic therapies with a fresh initiative—the RWE Co-Investment Program. This isn't your run-of-the-mill study announcement; it's a gutsy leap into largely unexplored areas of patient-reported outcomes and real-world evidence. A...

Continue Reading
Jill De Forest Honored: A Journey Through Recruitment

Updated Category News Views 74

A Force in Recruitment: Jill De Forest There's a name that reverberates through the corridors of executive search and recruitment: Jill De Forest. Recognized by The Inner Circle as the Pinnacle Professional of The Year, De Forest has left a profound mark on the industry with her knack for matching exceptional talent to major brands. Trailblazing through Executive Search...

Continue Reading
Longevity Tour Hits East Coast: Brecka's Mission

Updated Category News Views 135

Bringing Longevity to the East Coast This weekend, something interesting is happening on the East Coast of the U.S. Gary Brecka and his Ultimate Longevity Center (ULC) are holding a series of events in Philadelphia, New York, and Boston. Everything kicks off on November 14th. If the idea of 'live longevity' leaves you scratching your head, don’t worry—I've got you...

Continue Reading
Solar Cooking Revolution: InventHelp's Latest Innovation

Updated Category News Views 56

A Bright Idea Shines with Solar Cooking Some days, you stumble across an idea that just seems destined to shake things up, and COOK SOL SOLAR POWER COOKER might just be one of those spark plugs ready to ignite the world of outdoor cooking. Invented by a plucky thinker from Florence, South Carolina, this little gadget isn't just about frying up eggs on a camping trip. Nah,...

Continue Reading
MemryX AI's MX3+ Chip: A Game Changer For AI Workloads

Updated Category News Views 80

A New Benchmark in AI Acceleration Out of Ann Arbor, MemryX AI has thrown its hat into the ring with the latest in AI hardware wizardry—the MX3+ chip. Now this beige wonder promises to rev things up in the world of AI, boasting a tenfold increase in peak AI compute and upping the memory stakes by the same factor. All while sipping power like a polite fly at a soda...

Continue Reading
OptiMantra's AI Scribe: Transforming Clinic Workflows

Updated Category News Views 6

Cutting Through the Noise: AI Scribe's Pragmatic Impact OptiMantra's fresh launch of AI Scribe isn't just another gadget on the shelf—it's gunning for the throat of that time-sucking monster called after-hours charting. You'd think clinic management would be about patients first, right? But turns out, the devil's in the details, with docs burning midnight oil drafting...

Continue Reading
Clarivate's IPOne Revolutionizes AI for IP Pros

Updated Category News Views 44

A New Dawn for IP Intelligence: Clarivate's Strategic Move Seems like Clarivate's out to shake things up in the IP world. Today, they've announced that their coveted patent and litigation intelligence is now seamlessly integrated with AI workflows on Claude through IPOne. For those not neck-deep in patents and trademarks every day, let’s break it down. This means IP...

Continue Reading
Ascletis Targets Obesity with New FDA Submission

Updated Category News Views 51

Breaking Ground with Innovative Obesity Treatment In the world of biotech, where breakthroughs are hard-fought and the stakes can seem insurmountable, Ascletis Pharma is swinging for the fences with their latest maneuver. They've submitted an Investigational New Drug application to the U.S. Food and Drug Administration for ASC30_39 FDC—a pioneering fixed-dose combo pill...

Continue Reading
Contract Workers Gain Traction in Workforce Planning

Updated Category News Views 14

Contract Workers: The New Normal Ever feel like we're on a merry-go-round when it comes to workforce planning? Well, buckle up folks, because contract workers are becoming the mainstay of staffing strategies. According to a recent survey, 71% of U.S. companies are not just dabbling, but fully integrating these workers into their plans. That's a seismic shift from just a...

Continue Reading
Goranson Bain Ausley Welcomes Marichalar: Family Law Focus

Updated Category News Views 20

Strengthening San Antonio's Family Law Field Brenda Marichalar is joining the ranks at Goranson Bain Ausley (GBA) with a reputation built on solid courtroom chops and a knack for making clients feel like they’re more than just case numbers. She’s landing right in San Antonio, a region that’s not just about the riverwalks and missions, but about real families...

Continue Reading

Top 5 Most Recently Viewed Articles

United Texas Bank's Move to National Charter: Game Changer

Updated Category News Views 8

A Bold Leap in the Banking Landscape Right out of the gate, United Texas Bank (UTB) isn't just taking another step forward; they're sprinting into a whole new world. We're talking about an epic leap from being a solid regional player to potentially shaking up the entire industry. With a nod from the Office of the Comptroller of the Currency (OCC), UTB is now stepping up...

Continue Reading
FibroBiologics Showcases Innovation at Major European Conference

Updated Category News Views 145

FibroBiologics to Share Innovations at Bio-Europe FibroBiologics, Inc. (Nasdaq: FBLG), a pioneering biotechnology company based in Houston, is leading the charge in developing groundbreaking therapies aimed at chronic diseases. Their innovative approach focuses on using fibroblast cells and derived materials to spearhead medical advancements in treatment strategies....

Continue Reading
EU Lawmaker Advocates Bitcoin As Legal Tender In Europe

Updated Category News Views 424

Bitcoin's Potential as Legal Tender in Europe In an exciting conversation around the future of finance, Sarah Knafo, a member of the European Parliament from France, voiced her strong belief that Bitcoin could be recognized as legal tender in Europe. Knafo pointed out that the ongoing inflationary policies in traditional fiat currencies create a fertile ground for Bitcoin...

Continue Reading
BMO Sheds U.S. Branches, Eyes Strategic Growth

Updated Category News Views 36

Why BMO is Slimming Down in the States You know, when a heavyweight like BMO Financial Group starts shedding branches left and right, you gotta ask yourself what the grand plan is. In a move that looks more like a strategic dance than an abrupt U-turn, BMO's gotten rid of 138 U.S. branches, handing them over to First-Citizens Bank. We're talking outlets scattered from...

Continue Reading
HVAC Sensors Market Surge: Forecast to Reach $7.88 Billion

Updated Category News Views 215

HVAC Sensors Market Overview Austin—The HVAC Sensors market is experiencing notable growth, fueled by the increasing demand for energy-efficient solutions and smart building technologies. According to industry reports, the market was valued at USD 4.57 billion in 2024 and is projected to surge to USD 7.88 billion by 2032, reflecting a robust CAGR of 7.06% during the...

Continue Reading